Marshall Crenshaw, MD

Original Contribution

Efficacy and Safety of Percutaneous Life Support During High-Risk Percutaneous Coronary Intervention, Refractory Cardiogenic Shock and In-Laboratory Cardiopulmonary Arrest

03/25/2011

David Webb , MS, CCP;

Marshall Crenshaw , MD;

David X. Zhao , MD;

Ehab S. Kasasbeh , MD;

Joseph G. Salloum , MD;

Jack P. Chen , MD, FACC, FSCAI, FCCP;

Jayant Bagai , MD;

ABSTRACT: Background. High-risk percutaneous coronary interventions (PCI), refractory cardiogenic shock and in-lab cardiac arrest are all associated with significant mortality. Percutaneous left ventricular assist devices (pLVAD) and CPS...

ABSTRACT: Background. High-risk...

03/25/2011

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Marshall Crenshaw, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products